Invention Grant
- Patent Title: Antibodies to IL-34
-
Application No.: US17238549Application Date: 2021-04-23
-
Publication No.: US11649280B2Publication Date: 2023-05-16
- Inventor: Marcio Chedid , Victor H. Obungu , Andrew Dixon Skora , Ming Ye
- Applicant: Eli Lilly and Company
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Dan L. Wood
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24 ; G01N33/577 ; G01N33/68 ; A61K39/00
Abstract:
The present invention relates to IL-34 antibodies, compositions comprising the same, and methods of using the antibodies and or compositions thereof for treating immune-mediated diseases such as neurodegenerative diseases, for example Alzheimer's Disease or a tauopathy disease.
Public/Granted literature
- US20210363232A1 COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34 Public/Granted day:2021-11-25
Information query
